Pharma giant overcomes patent expiry of arthritis blockbuster Remicade and fallingmedical device sales
Gains from its acquisition of Swiss biotech Actelion also helped the bottom line
Second quarter earnings beat forecasts despite slight fall in pharma division
Financial stocks among main Dublin movers, with Bank of Ireland up 1.5% and Permanent TSB gaining 3.4%
Company to become leader in medicines treating rare type of high blood pressure
Negotiations between the two companies had ended earlier this month
Miners and technology shares fall most, while travel and energy shares rise in final week
Earlier negotiations between pharmaceutical firms ended a week ago without a deal
Share price had fallen by 7% recently as possible takeover of the firm failed to emerge
Two-week rally driven by rebound in beaten-down banking shares; dollar pauses
Wall Street fluctuates on interest rates rise as Fed says increases will be gradual
Swiss drugmaker Roche also touted as possible buyer for Europe’s largest biotech firm
Trading remains thin ahead of Opec meeting and Italian referendum this weekend
Doubts persist over oil cartel’s ability to agree output cut as Wednesday meeting nears
YOU MAY ALSO LIKE...
How does a post-Brexit world shape the identity and relationship of these islands
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices